ES
Elphogene develops liquid biopsy testing tools that utilize circulating tumor DNA analysis to detect cancer at early stages. This technology provides oncologists with non-invasive diagnostic options, improving patient outcomes by enabling timely treatment decisions.
Updated 2 months ago
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
II
Funding rounds are not available yet.
Founders
Product
Features
- Elphogene develops liquid biopsy testing tools that utilize circulating tumor DNA analysis to detect cancer at early stages. This technology provides oncologists with non-invasive diagnostic options, improving patient outcomes by enabling timely treatment decisions.